Author:
Connor Kathryn M.,Sutherland Suzanne M.,Tupler Larry A.,Malik Mary L.,Jonathan R.,Davidson T.
Abstract
BackgroundMost pharmacotherapy trials in post-traumatic stress disorder (PTSD) have been conducted upon male combat veterans. Outcome studies relating to civilians are therefore needed.AimsTo demonstrate that fluoxetine is more effective than placebo in treating PTSD.MethodCivilians with PTSD (n=53) were treated for 12 weeks with fluoxetine (up to 60 mg/day) or placebo. Assessments of PTSD severity, disability, stress vulnerability, and high end-state function were obtained.ResultsFluoxetine was more effective than placebo on most measures at week 12, including global improvement (much or very much improved: fluoxetine 85%, placebo 62%, difference 0.24, 95% CI 0.01–0.47; very much improved: fluoxetine 59%, placebo 19%, difference 0.40, 95% CI 0.16–0.64), and high end-state function (fluoxetine 41%, placebo 4%, difference 0.37, 95% CI 0.17–0.57)ConclusionsFluoxetine was superior for measures of PTSD severity, disability, stress vulnerability, and high end-state function. The placebo-group response was low when viewed as a broad outcome based on a portfolio of ratings, but was higher with a traditional global rating criterion.
Publisher
Royal College of Psychiatrists
Subject
Psychiatry and Mental health
Reference21 articles.
1. Fluoxetine in posttraumatic stress disorder;van der Kolk;Journal of Clinical Psychiatry,1994
2. Assessment of a new self-rating scale for post-traumatic
stress disorder
3. Biological therapies for posttraumatic stress disorder: an overview;Davidson;Journal of Clinical Psychiatry,1997
Cited by
230 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献